Travis C. Mickle is CEO & President +1 at KEMPHARM, INC (KMPH). They have made 1 open-market trade across 1 company since 2019, most recently 2019-09-24.
CIK 0001638365
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $39K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KMPH | 1,743,117 | $10.1M |
Shares reported on the most recent Form 4, priced at the 2019-09-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KMPH | BUY | 2019-09-24 | 2019-09-24 | $0.79 | $39K | -11.7% | -35.8% | -60.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.